ТИРОНЕТ – все о щитовидной железе Для специалистов Журнал Тиронет 2011 год № 1

Клинические рекомендации по диагностике и лечению узлового зоба

Махмуд Хариб, Хоссейн Хариб.
Перевод В.В. Фадеева

Список литературы

  1. Gharib H, Papini E, Paschke R, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical Guidelines for Clinical Pratice for the Diagnosis and Management of Thyroid Nodules. Endocr Pract 2010;16:1-43.

  2. Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules: final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med 1968;69:537-40.

  3. Rojeski MT, Gharib H. Nodular thyroid disease: evaluation and management. N Engl J Med 1985;313:428-36.

  4. Ezzat S, Sarti DA, Cain DR, et al. Thyroid incidentalomas: prevalence by palpation and ultrasonography. Arch Intern Med 1994;154:1838-40.

  5. Mortensen JD, Woolner LB, Bennett WA. Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab 1955;15:1270-80.

  6. Tan GH, Gharib H, Reading CC. Solitary thyroid nodule: comparison between palpation and ultrasonography. Arch Intern Med 1995;155:2418-23.

  7. Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997;126:226-31.

  8. Burguera B, Gharib H. Thyroid incidentalomas: prevalence, diagnosis, significance, and management. Endocrinol Metab Clin North Am 2000;29:187-203.

  9. Boelaert K, et al. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by FNA. J Clin Endocrinol Metab 2006; 91:4295-301.

  10. Haymart MR, Repplinger DJ, Leverson GE et al. Higher serum TSH in thyroid nodule patients is associated with greater risk of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metabol 2008;93:809-14.

  11. Gharib H, Papini E. Thyroid nodules: Clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am 2007:707-35.

  12. Mandel SJ. Diagnostic use of ultrasonography in patients with nodular thyroid disease. Endocr Pract 2004;10:246-52.

  13. Hegedus L. Clinical practice: the thyroid nodule. N Engl J Med 2004;351:1764-71.

  14. Frates MC, Benson CB, Charboneau JW et al; Society of Radiologists in Ultrasound. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology 2005;237:794-800.

  15. Papini E, Guglielmi R, Bianchini A et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002;87:1941-6.

  16. Carmeci C, Jeffrey RB, McDougall IR et al. Ultrasoundguided fine-needle aspiration biopsy of thyroid masses. Thyroid 1998;8:283-9.

  17. Cochand-Priollet B, Guillausseau PJ, Chagnon S et al. The diagnostic value of fine-needle aspiration biopsy under ultrasonography in nonfunctional thyroid nodules: a prospective study comparing cytologic and histologic find- ings. Am Med 1994;97:152-7. Erratum in: Am J Med 1994;97:311.

  18. Pacini F, Fontanelli M, Fugazzola L et al. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 1994;78:826-9.

  19. Niccoli P, Wion-Barbot N, Caron P et al; The French Medullary Study Group. Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. J Clin Endocrinol Metab 1997;82:338-41.

  20. Elisei R, Bottici V, Luchetti F et al. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 2004;89:163-8.

  21. Gharib H. Changing concepts in the diagnosis and management of thyroid nodules. Endocrinol Metab Clin North Am 1997;26:777-800.

  22. Gharib H. Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect. Mayo Clin Proc 1994;69:44-9.

  23. Goellner JR, Gharib H, Grant CS et al. Fine — needle aspiration cytology of the thyroid, 1980 to 1986. Acta Cytol 1987;31:587-90.

  24. Gharib H, Goellner JR. Fine-needle aspiration biopsy of thyroid nodules. Endocr Pract 1995;1:410-7.

  25. Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 1993;118:282-9.

  26. AACE/AME Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 2006;12:63-102.

  27. Gharib H, Mazzaferri EL. Thyroxine suppressive therapy in patients with nodular thyroid disease. Ann Intern Med 1998;128:386-94.

  28. Castro MR, Gharib H. Continuing controversies in the management of thyroid nodules. Ann Intern Med 2005;142:926-31.

  29. Lippi F, Manetti L, Rago T. Percutaneous ultrasoundguided ethanol injection for treatment of autonomous thyroid nodules: results of a multicentric study [abstract]. J Endocrinol Invest 1994;17 Suppl 2:71.

  30. Zingrillo M, Torlontano M, Chiarella R et al. Percutaneous ethanol injection may be a definitive treatment for symptomatic thyroid cystic nodules not treatable by surgery: five-year follow-up study. Thyroid 1999;9:763-7.

  31. Kim JH, Lee HK, Lee JH et al. Efficacy of sonographically guided percutaneous ethanol injection for treatment of thyroid cysts versus solid thyroid nodules. AJR Am J Roentgenol 2003;180:1723-6.

  32. Valcavi R, Frasoldati A. Ultrasound-guided percutaneous ethanol injection therapy in thyroid cystic nodules. Endocr Pract 2004;10:269-75.

  33. Guglielmi R, Pacella CM, Bianchini A et al. Percutaneous ethanol injection treatment in benign thyroid lesions: role and efficacy. Thyroid 2004;14:125-31.

  34. Bennedbaek FN, Hegedus L. Treatment of recurrent thyroid cysts with ethanol: a randomized double-blind controlled trial. J Clin Endocrinol Metab 2003;88:5773-7.

  35. Papini E, Panunzi C, Pacella CM et al. Percutaneous ultrasoundguided ethanol injection: a new treatment of toxic autonomously functioning thyroid nodules? J Clin Endocrinol Metab 1993;76:411-6.

  36. Gharib H, Goellner JR, Zinsmeister AR, et al. Fine-needle aspiration biopsy of the thyroid: the problem of suspicious cytologic findings. Ann Intern Med 1984;101:25-8.

  37. Segev DL, Clark DP, Zieger MA, et al. Beyond the suspicious thyroid fine needle aspirate: a review. Acta Cytol 2003;47:709-22.

  38. Bartolazzi A, Gasbarri A, Papotti M et al; Thyroid Cancer Study Group. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 2001;357:1644-50.

  39. Castro MR, Gharib H. Thyroid fine-needle aspiration biopsy: progress, practice, and pitfalls. Endocr Pract 2003;9:128-36.

  40. Miettinen M, Karkkainen P. Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumors: preferential reactivity with malignant tumours. Virchows Arch 1996;429:213-9.

  41. Huysmans DA, Hermus AR, Corstens FH et al. Large, compressive goiters treated with radioiodine. Ann Intern Med 1994;121:757-62.

  42. Hegedus L, Hansen BM, Knudsen N et al. Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goitre. BMJ 1988;297:661-2.

  43. Nygaard B, Hegedus L, Gervil M et al. Radioiodine treatment of multinodular nontoxic goitre. BMJ 1993;307:828-32.

  44. de Klerk J, van Isselt JW, van Dijk A et al. Iodine-131 therapy in sporadic nontoxic goiter. J Nucl Med 1997;38:372-6.

  45. Silva MN, Rubio IG, Knobel M et al. Treatment of multinodular goiters in elderly patients with therapeutic doses of radioiodine preceded by stimulation with human recombinant TSH. Endocr J 2000;47 Suppl;144.

  46. Duick DS, Baskin HJ. Utility of recombinant human thyrotropin for augmentation of radioiodine uptake and treatment of nontoxic and toxic multinodular goiters. Endocr Pract 2003;9:204-9.

  47. Duick DS, Baskin HJ. Significance of radioiodine uptake at 72 hours versus 24 hours after pretreatment with recombinant human thyrotropin for enhancement of radioiodine therapy in patients with symptomatic nontoxic or toxic multinodular goiter. Endocr Pract 2004;10:253-60.

  48. Bonnema SJ, Hegedus L. A 30-year perspective on radioiodine therapy of benign nontoxic multinodular goiter. Curr Opin Diabetes Obes 2009;16:379-84.

  49. Nielsen VE, Bonnema SJ, Hegedus L. Transient goiter enlargement after administration of 0.3 mg of recombinant human thyrotropin in patients with benign nontoxic nodular goiter: a randomized, double-blind, crossover trial. J Clin Endocrinol Metab 2006; 91:1317-22.